Skip to main content
Top
Published in: BMC Medicine 1/2022

Open Access 01-12-2022 | Type 2 Diabetes | Research article

Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries

Authors: Johnny T. K. Cheung, Eric Lau, Cyrus C. T. Tsui, Edmond L. N. Siu, Naomi K. W. Tse, Nicole Y. L. Hui, Ronald C. W. Ma, Alice P. S. Kong, Amy Fu, Vanessa Lau, Weiping Jia, Wayne H. H. Sheu, Leorino Sobrepena, K. H. Yoon, Alexander T. B. Tan, Yook-Chin Chia, Aravind Sosale, Banshi D. Saboo, Jothydev Kesavadev, Su-Yen Goh, Thy Khue Nguyen, Yotsapon Thewjitcharoen, Raymond Suwita, Andrea O. Y. Luk, Aimin Yang, Elaine Chow, Lee Ling Lim, Juliana C. N. Chan

Published in: BMC Medicine | Issue 1/2022

Login to get access

Abstract

Background

Family history (FamH) of type 2 diabetes might indicate shared genotypes, environments, and/or behaviors. We hypothesize that FamH interacts with unhealthy behaviors to increase the risk of early onset of diabetes and poor cardiometabolic control.

Methods

In a cross-sectional analysis of the prospective Joint Asia Diabetes Evaluation Register including patients from 427 clinics in 11 Asian countries/regions in 2007–2021, we defined positive FamH as affected parents/siblings and self-management as (1) healthy lifestyles (balanced diet, non-use of alcohol and tobacco, regular physical activity) and (2) regular self-monitoring of blood glucose (SMBG).

Results

Among 86,931 patients with type 2 diabetes (mean±SD age: 56.6±11.6 years; age at diagnosis of diabetes: 49.8±10.5 years), the prevalence of FamH ranged from 39.1% to 85.3% in different areas with FamH affecting mother being most common (32.5%). The FamH group (n=51,705; 59.5%) was diagnosed 4.6 years earlier than the non-FamH group [mean (95% CI): 47.9 (47.8–48.0) vs. 52.5 (52.4–52.6), logrank p<0.001]. In the FamH group, patients with both parents affected had the earliest age at diagnosis [44.6 (44.5–44.8)], followed by affected single parent [47.7 (47.6–47.8)] and affected siblings only [51.5 (51.3–51.7), logrank p<0.001]. The FamH plus ≥2 healthy lifestyle group had similar age at diagnosis [48.2 (48.1–48.3)] as the non-FamH plus <2 healthy lifestyle group [50.1 (49.8–50.5)]. The FamH group with affected parents had higher odds of hyperglycemia, hypertension, and dyslipidemia than the FamH group with affected siblings, with the lowest odds in the non-FamH group. Self-management (healthy lifestyles plus SMBG) was associated with higher odds of attaining HbA1c<7%, blood pressure<130/80mmHg, and LDL-C<2.6 mmol/L especially in the FamH group (FamH×self-management, pinteraction=0.050–0.001).

Conclusions

In Asia, FamH was common and associated with young age of diagnosis which might be delayed by healthy lifestyle while self management  was associated with better control of  cardiometabolic risk factors especially in those with FamH.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.PubMedCrossRef Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.PubMedCrossRef
2.
go back to reference Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396:2019–82.PubMedCrossRef Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396:2019–82.PubMedCrossRef
3.
go back to reference Chan JCN, Yeung R, Luk A. The Asian diabetes phenotypes: challenges and opportunities. Diabetes Res Clin Pract. 2014;105:135–9.PubMedCrossRef Chan JCN, Yeung R, Luk A. The Asian diabetes phenotypes: challenges and opportunities. Diabetes Res Clin Pract. 2014;105:135–9.PubMedCrossRef
4.
go back to reference Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421 LP–426.CrossRef Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421 LP–426.CrossRef
5.
go back to reference Tabish SA. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci (Qassim). 2007;1:V–VIII.PubMedCentral Tabish SA. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci (Qassim). 2007;1:V–VIII.PubMedCentral
6.
go back to reference Luk AOY, Ke C, Lau ESH, Wu H, Goggins W, Ma RCW, et al. Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study. PLOS Med. 2020;17:e1003052.PubMedPubMedCentralCrossRef Luk AOY, Ke C, Lau ESH, Wu H, Goggins W, Ma RCW, et al. Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study. PLOS Med. 2020;17:e1003052.PubMedPubMedCentralCrossRef
7.
go back to reference Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376:1419–29.PubMedPubMedCentralCrossRef Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376:1419–29.PubMedPubMedCentralCrossRef
8.
go back to reference Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon K-H, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2:935–43.PubMedCrossRef Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon K-H, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2:935–43.PubMedCrossRef
9.
go back to reference Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465–74.PubMedCrossRef Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465–74.PubMedCrossRef
10.
go back to reference Ke C, Lau E, Shah BR, Stukel TA, Ma RC, So W-Y, et al. Excess burden of mental illness and hospitalization in young-onset type 2 diabetes. Ann Intern Med. 2019;170:145–54.PubMedCrossRef Ke C, Lau E, Shah BR, Stukel TA, Ma RC, So W-Y, et al. Excess burden of mental illness and hospitalization in young-onset type 2 diabetes. Ann Intern Med. 2019;170:145–54.PubMedCrossRef
11.
go back to reference Papazafiropoulou AK, Papanas N, Melidonis A, Maltezos E. Family history of type 2 diabetes: does having a diabetic parent increase the risk? Curr Diabetes Rev. 2017;13:19–25.PubMedCrossRef Papazafiropoulou AK, Papanas N, Melidonis A, Maltezos E. Family history of type 2 diabetes: does having a diabetic parent increase the risk? Curr Diabetes Rev. 2017;13:19–25.PubMedCrossRef
13.
go back to reference Poulsen P, Grunnet LG, Pilgaard K, Storgaard H, Alibegovic A, Sonne MP, et al. Increased risk of type 2 diabetes in elderly twins. Diabetes. 2009;58:1350–5.PubMedPubMedCentralCrossRef Poulsen P, Grunnet LG, Pilgaard K, Storgaard H, Alibegovic A, Sonne MP, et al. Increased risk of type 2 diabetes in elderly twins. Diabetes. 2009;58:1350–5.PubMedPubMedCentralCrossRef
14.
go back to reference Noh J-W, Jung JH, Park JE, Lee JH, Sim KH, Park J, et al. The relationship between age of onset and risk factors including family history and life style in Korean population with type 2 diabetes mellitus. J Phys Ther Sci. 2018;30:201–6.PubMedPubMedCentralCrossRef Noh J-W, Jung JH, Park JE, Lee JH, Sim KH, Park J, et al. The relationship between age of onset and risk factors including family history and life style in Korean population with type 2 diabetes mellitus. J Phys Ther Sci. 2018;30:201–6.PubMedPubMedCentralCrossRef
15.
go back to reference Jeong SU, Kang DG, Lee DH, Lee KW, Lim D-M, Kim BJ, et al. Clinical characteristics of type 2 diabetes patients according to family history of diabetes. Korean Diabetes J. 2010;34:222–8.PubMedPubMedCentralCrossRef Jeong SU, Kang DG, Lee DH, Lee KW, Lim D-M, Kim BJ, et al. Clinical characteristics of type 2 diabetes patients according to family history of diabetes. Korean Diabetes J. 2010;34:222–8.PubMedPubMedCentralCrossRef
16.
go back to reference Geetha A, Gopalakrishnan S, Umadevi R. Study on the impact of family history of diabetes among type 2 diabetes mellitus patients in an urban area of Kancheepuram district, Tamil Nadu. Int J Community Med Public Heal. 2017;4:4151–6.CrossRef Geetha A, Gopalakrishnan S, Umadevi R. Study on the impact of family history of diabetes among type 2 diabetes mellitus patients in an urban area of Kancheepuram district, Tamil Nadu. Int J Community Med Public Heal. 2017;4:4151–6.CrossRef
17.
go back to reference Hermans MP, Ahn SA, Rousseau MF. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring. J Diabetes. 2019;11:301–8.PubMedCrossRef Hermans MP, Ahn SA, Rousseau MF. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring. J Diabetes. 2019;11:301–8.PubMedCrossRef
18.
go back to reference Ng MC, Lee SC, Ko GT, Li JK, So WY, Hashim Y, et al. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabetes Care. 2001;24:663–71.PubMedCrossRef Ng MC, Lee SC, Ko GT, Li JK, So WY, Hashim Y, et al. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabetes Care. 2001;24:663–71.PubMedCrossRef
19.
go back to reference Li JKY, Ng MCY, So WY, Chiu CKP, Ozaki R, Tong PCY, et al. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2006;22:46–52.PubMedCrossRef Li JKY, Ng MCY, So WY, Chiu CKP, Ozaki R, Tong PCY, et al. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2006;22:46–52.PubMedCrossRef
20.
go back to reference Wu H, Lau ES, Kong AP, Ma RC, Ozaki R, Cheung KK, et al. Association between educational level and cardiovascular disease and all-cause mortality in patients with type 2 diabetes: a prospective study in the Joint Asia Diabetes Evaluation Program. Clin Epidemiol. 2018;10:1561–71.PubMedPubMedCentralCrossRef Wu H, Lau ES, Kong AP, Ma RC, Ozaki R, Cheung KK, et al. Association between educational level and cardiovascular disease and all-cause mortality in patients with type 2 diabetes: a prospective study in the Joint Asia Diabetes Evaluation Program. Clin Epidemiol. 2018;10:1561–71.PubMedPubMedCentralCrossRef
21.
go back to reference Cho NH, Chan JCN, Jang HC, Lim S, Kim HL, Choi SH. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf). 2009;71:679–85.PubMedCrossRef Cho NH, Chan JCN, Jang HC, Lim S, Kim HL, Choi SH. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf). 2009;71:679–85.PubMedCrossRef
22.
go back to reference Choi J, Choi J-Y, Lee S-A, Lee K-M, Shin A, Oh J, et al. Association between family history of diabetes and clusters of adherence to healthy behaviors: cross-sectional results from the Health Examinees-Gem (HEXA-G) study. BMJ Open. 2019;9:e025477.PubMedPubMedCentralCrossRef Choi J, Choi J-Y, Lee S-A, Lee K-M, Shin A, Oh J, et al. Association between family history of diabetes and clusters of adherence to healthy behaviors: cross-sectional results from the Health Examinees-Gem (HEXA-G) study. BMJ Open. 2019;9:e025477.PubMedPubMedCentralCrossRef
23.
go back to reference Chan JCN, Lim L-L, Luk AOY, Ozaki R, Kong APS, Ma RCW, et al. From Hong Kong Diabetes Register to JADE Program to RAMP-DM for data-driven actions. Diabetes Care. 2019;42:2022–31.PubMedCrossRef Chan JCN, Lim L-L, Luk AOY, Ozaki R, Kong APS, Ma RCW, et al. From Hong Kong Diabetes Register to JADE Program to RAMP-DM for data-driven actions. Diabetes Care. 2019;42:2022–31.PubMedCrossRef
24.
go back to reference American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2020;44 Supplement_1:S15–33. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2020;44 Supplement_1:S15–33.
25.
go back to reference Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med. 1993;10:371–7.PubMedCrossRef Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med. 1993;10:371–7.PubMedCrossRef
26.
go back to reference Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41:2669–701.PubMedPubMedCentralCrossRef Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41:2669–701.PubMedPubMedCentralCrossRef
27.
go back to reference Chan JCN, Gagliardino JJ, Baik SH, Chantelot J-M, Ferreira SRG, Hancu N, et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care. 2009;32:227–33.PubMedPubMedCentralCrossRef Chan JCN, Gagliardino JJ, Baik SH, Chantelot J-M, Ferreira SRG, Hancu N, et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care. 2009;32:227–33.PubMedPubMedCentralCrossRef
28.
go back to reference Kong APS, Yang X, Ko GTC, So W-Y, Chan W-B, Ma RCW, et al. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care. 2007;30:953–9.PubMedCrossRef Kong APS, Yang X, Ko GTC, So W-Y, Chan W-B, Ma RCW, et al. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care. 2007;30:953–9.PubMedCrossRef
29.
go back to reference Molyneaux L, Constantino M, Yue D. Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes. Diabetes Obes Metab. 2004;6:187–94.PubMedCrossRef Molyneaux L, Constantino M, Yue D. Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes. Diabetes Obes Metab. 2004;6:187–94.PubMedCrossRef
30.
go back to reference Mozaffarian D, Kamineni A, Carnethon M, Djoussé L, Mukamal KJ, Siscovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med. 2009;169:798–807.PubMedPubMedCentralCrossRef Mozaffarian D, Kamineni A, Carnethon M, Djoussé L, Mukamal KJ, Siscovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med. 2009;169:798–807.PubMedPubMedCentralCrossRef
31.
go back to reference Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40:679–86.PubMedPubMedCentralCrossRef Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40:679–86.PubMedPubMedCentralCrossRef
33.
go back to reference Li-Ng M, Tropp S, Danoff A, Bini EJ. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis. 2007;39:549–56.PubMedCrossRef Li-Ng M, Tropp S, Danoff A, Bini EJ. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis. 2007;39:549–56.PubMedCrossRef
34.
go back to reference Lao TT, Chan BCP, Leung W-C, Ho L-F, Tse K-Y. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol. 2007;47:46–50.PubMedCrossRef Lao TT, Chan BCP, Leung W-C, Ho L-F, Tse K-Y. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol. 2007;47:46–50.PubMedCrossRef
35.
go back to reference Wang J-S, Lo S-H, Yeh Y-P, Hwu C-M, Huang C-N, Hsieh C-H, et al. Distinct associations of self-monitoring of blood glucose with glycemic control and hypoglycemia between groups of recently diagnosed and long-term follow-up type 2 diabetes: the Taiwan Diabetes Registry. Int J Clin Pract. 2021;00:e14410. Wang J-S, Lo S-H, Yeh Y-P, Hwu C-M, Huang C-N, Hsieh C-H, et al. Distinct associations of self-monitoring of blood glucose with glycemic control and hypoglycemia between groups of recently diagnosed and long-term follow-up type 2 diabetes: the Taiwan Diabetes Registry. Int J Clin Pract. 2021;00:e14410.
36.
go back to reference Chan JCN, Ozaki R, Luk A, Kong APS, Ma RCW, Chow FCC, et al. Delivery of integrated diabetes care using logistics and information technology-the Joint Asia Diabetes Evaluation (JADE) program. Diabetes Res Clin Pract. 2014;106(Suppl):S295–304.PubMedCrossRef Chan JCN, Ozaki R, Luk A, Kong APS, Ma RCW, Chow FCC, et al. Delivery of integrated diabetes care using logistics and information technology-the Joint Asia Diabetes Evaluation (JADE) program. Diabetes Res Clin Pract. 2014;106(Suppl):S295–304.PubMedCrossRef
37.
go back to reference Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018;6:130–42.PubMedCrossRef Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018;6:130–42.PubMedCrossRef
38.
go back to reference Lim L-L, Lau ESH, Fu AWC, Ray S, Hung Y-J, Tan ATB, et al. Effects of a technology-assisted integrated diabetes care program on cardiometabolic risk factors among patients with type 2 diabetes in the Asia-Pacific region: the JADE Program randomized clinical trial. JAMA Netw Open. 2021;4:e217557.PubMedPubMedCentralCrossRef Lim L-L, Lau ESH, Fu AWC, Ray S, Hung Y-J, Tan ATB, et al. Effects of a technology-assisted integrated diabetes care program on cardiometabolic risk factors among patients with type 2 diabetes in the Asia-Pacific region: the JADE Program randomized clinical trial. JAMA Netw Open. 2021;4:e217557.PubMedPubMedCentralCrossRef
39.
go back to reference Chan JCN, Thewjitcharoen Y, Nguyen TK, Tan A, Chia Y-C, Hwu C-M, et al. Effect of a web-based management guide on risk factors in patients with type 2 diabetes and diabetic kidney disease: a JADE randomized clinical trial. JAMA Netw Open. 2022;5:e223862.PubMedPubMedCentralCrossRef Chan JCN, Thewjitcharoen Y, Nguyen TK, Tan A, Chia Y-C, Hwu C-M, et al. Effect of a web-based management guide on risk factors in patients with type 2 diabetes and diabetic kidney disease: a JADE randomized clinical trial. JAMA Netw Open. 2022;5:e223862.PubMedPubMedCentralCrossRef
40.
go back to reference Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (The Diabetes & Aging Study). Diabetes Care. 2019;42:416–26.PubMedCrossRef Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (The Diabetes & Aging Study). Diabetes Care. 2019;42:416–26.PubMedCrossRef
41.
go back to reference Ke C, Stukel TA, Shah BR, Lau E, Ma RC, So W-Y, et al. Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study. PLoS Med. 2020;17:e1003316.PubMedPubMedCentralCrossRef Ke C, Stukel TA, Shah BR, Lau E, Ma RC, So W-Y, et al. Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study. PLoS Med. 2020;17:e1003316.PubMedPubMedCentralCrossRef
42.
go back to reference Lim LL, Lau ESH, Kong APS, Davies MJ, Levitt NS, Eliasson B, et al. Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis. Diabetes Care. 2018;41:1312–20.PubMedPubMedCentralCrossRef Lim LL, Lau ESH, Kong APS, Davies MJ, Levitt NS, Eliasson B, et al. Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis. Diabetes Care. 2018;41:1312–20.PubMedPubMedCentralCrossRef
Metadata
Title
Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries
Authors
Johnny T. K. Cheung
Eric Lau
Cyrus C. T. Tsui
Edmond L. N. Siu
Naomi K. W. Tse
Nicole Y. L. Hui
Ronald C. W. Ma
Alice P. S. Kong
Amy Fu
Vanessa Lau
Weiping Jia
Wayne H. H. Sheu
Leorino Sobrepena
K. H. Yoon
Alexander T. B. Tan
Yook-Chin Chia
Aravind Sosale
Banshi D. Saboo
Jothydev Kesavadev
Su-Yen Goh
Thy Khue Nguyen
Yotsapon Thewjitcharoen
Raymond Suwita
Andrea O. Y. Luk
Aimin Yang
Elaine Chow
Lee Ling Lim
Juliana C. N. Chan
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Type 2 Diabetes
Published in
BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-022-02424-y

Other articles of this Issue 1/2022

BMC Medicine 1/2022 Go to the issue